Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Sponsored by Oculis
About this study
The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).
Where this study is enrolling (3)
- I'm interested
Kahana Oculoplastic and Orbital Surgery
Livonia, Michigan
- I'm interested
Neuro-Eye Clinical Trials
Houston, Texas
- I'm interested
UT Southwestern Medical Center (Ophthalmology CRU)
Dallas, Texas
Who can participate
Inclusion criteria
- ✓Adult men and women (aged 18 to 50 years) with the first episode of ON in the study eye, associated with unilateral visual loss.
- ✓Onset of visual loss symptoms in the previous 12 days before first administration of study treatment.
Exclusion criteria
- ✕\- Have a history or presence of any disorder or condition that may, in the opinion of the Investigator, likely interfere with the interpretation of the study results or participant safety
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.